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Despite the development in recent times of a range of
techniques for phasing macromolecules, the conventional
heavy-atom derivatization method still plays a signiﬁcant role
in protein structure determination. However, this method has
become less popular in modern high-throughput oriented
crystallography, mostly owing to its trial-and-error nature,
which often results in lengthy empirical searches requiring
large numbers of well diffracting crystals. In addition, the
phasing power of heavy-atom derivatives is often compro-
mised by lack of isomorphism or even loss of diffraction. In
order to overcome the difﬁculties associated with the
‘classical’ heavy-atom derivatization procedure, an attempt
has been made to develop a rational crystal-free heavy-atom
derivative-screening method and a quick-soak derivatization
procedure which allows heavy-atom compound identiﬁcation.
The method includes three basic steps: (i) the selection of
likely reactive compounds for a given protein and speciﬁc
crystallization conditions based on pre-deﬁned heavy-atom
compound reactivity proﬁles, (ii) screening of the chosen
heavy-atom compounds for their ability to form protein
adducts using mass spectrometry and (iii) derivatization of
crystals with selected heavy-metal compounds using the quick-
soak method to maximize diffraction quality and minimize
non-isomorphism. Overall, this system streamlines the process
of heavy-atom compound identiﬁcation and minimizes the
problem of non-isomorphism in phasing.
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1. Introduction
The use of heavy-atom phasing still remains a major technique
in de novo macromolecular crystal structure determination.
However, there are a number of difﬁculties associated with the
technique which have limited its widespread use in recent
years. The traditional method usually entails the soaking of
multiple crystals in numerous heavy-atom compound solu-
tions for days to weeks (Blundell & Johnson, 1976). The
success of a derivatization is then evaluated through X-ray
diffraction data analysis. While the method has been highly
utilized in the past, it is too inefﬁcient to support the demands
of modern crystallography. The obvious difﬁculties in the
conventional heavy-atom derivative-screening process are
that (i) it is an empirical hit-or-miss process based on random
screening of numerous heavy-atom compounds, (ii) it requires
multiple crystals and (iii) it is a lengthy process requiring
multiple X-ray data acquisitions and analyses. The expecta-
tions of high-throughput structure determination demand a
new, rapid and rational heavy-atom screening procedure.
Additionally, the ever-increasing application of crystallo-graphy to difﬁcult projects with often limited amounts of
protein samples and crystals make the lengthy routine
screening of heavy-atom derivatives impractical.
Here, we summarize the development of a rapid rational
procedure for the identiﬁcation of heavy-atom compounds for
phasing. Speciﬁcally, we have developed an approach to
enable the selection of heavy-atom compounds based on
known reactivities in speciﬁc crystallization conditions
(Agniswamy et al., 2008). Mass spectrometry is then used to
provide a reliable, rapid and crystal-free method for assessing
the likely heavy-atom compounds for derivatization (Sun &
Hammer, 2000). A quick-soak method is then used to mini-
mize non-isomorphism and maximize the phasing power of
heavy-atom derivatives (Sun et al., 2002; Sun & Radaev, 2002).
2. Selection of reactive heavy-atom compounds based
on their reactivity profiles
The heavy-metal compounds used in crystallography are
generally classiﬁed as either class A or class B (Blundell &
Johnson, 1976; Blundell & Jenkins, 1977). Class A heavy-metal
compounds, such as the lanthanides and actinides (primarily
uranium), tend to bind to electronegative protein ligands
through charge interactions, e.g. UO2
2+ binds to the carbox-
ylate group of glutamate and aspartate, as seen in the heavy-
atom-bound insulin structure (Blundell et al., 1971) and also in
the prealbumin structure (Blake et al., 1974). In contrast, class
B metals such as platinum, gold and mercury bind covalently
to reactive amines and sulfhydryl groups (Islam et al., 1998;
Rould, 1997). However, other class B metals such as lead
and thallium show a different reactivity and tend to interact
with hydroxyl groups. Successful heavy-atom derivatization
depends not only on the availability of speciﬁc amino-acid
ligands in a given protein but also to a great extent on the
crystallization conditions. Buffer and pH are known to affect
the reactivity and solubility of heavy-atom compounds both
through chelating heavy atoms and inﬂuencing the protona-
tion state of the reactive groups.
To systematically assess the effect of buffer on heavy-atom
reactivities, we carried out a series of derivatization experi-
ments using peptides with a single reactive residue (e.g. the
methionine-containing peptide GEAGMASAGGAG) and
class B heavy-metal compounds. These heavy-atom com-
pounds generally form covalent adducts with amino-acid
ligands and their reactivity depends less on the tertiary
conformation of the ligands. Peptides with a single cysteine,
methionine or histidine residue were assessed for reactivity
with platinum, gold and mercury compounds, while peptides
containing a single aspartate, glutamate, asparagine, glutamine
or tyrosine residue were used in derivatization experiments
with lead-containing compounds. A total of 43 heavy-atom
compounds were tested for peptide reactivity in 12 buffer
conditions over a wide range of pH. The results are tabulated
in Agniswamy et al. (2008) and can be found at http://
sis.niaid.nih.gov/cgi-bin/heavyatom_reactivity.cgi. The data-
base can be used to select compounds that are likely to deri-
vatize a given protein of interest under selected buffer
conditions.
As expected, heavy-metal compound reactivities depend
strongly on buffer and pH conditions. Overall, MES and
citrate buffers are the most and least supportive for heavy-
atom derivatization experiments, respectively (Table 1).
Therefore, proteins crystallized under MES buffer conditions
are likely to be derivatized by a larger range of compounds
than those crystallized in any other buffer. Among the basic
pH buffers, reactions carried out in HEPES buffer have a
greater success rate than those carried out in Tris buffers.
However, depending on the peptide ligands available, heavy
atoms may react preferentially in either HEPES or Tris buffer.
The pH preference of heavy-metal reactivity is also apparent
from this study. Gold potassium bromide, potassium tetra-
bromoaurate, gold potassium thiocyanide and trimethyllead
acetate (TMLA) all show high levels of derivatization at
slightly acidic to basic pH values, while potassium tetra-
cyanoplatinate, gold sodium thiosulfate, mercury(II) chloride,
methylmercury(II) bromide, p-chloromercuric benzoic acid,
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Table 1
List of the most reactive compounds for heavy-atom derivatization of
proteins.
Ranking of the most reactive compounds Derivatization (%)
Ethylmercury(II) phosphate 69.4
Methylmercury(II) acetate 66.6
Sodium tetrachloroaurate 61.1
Potassium tetrabromoplatinate 55.5
Potassium tetrachloroaurate 52.7
Ammonium tetrachloroplatinate 50.0
Gold(III) chloride 47.2
Diaminoplatinum dinitrate 47.2
Thiomersal 47.2
Mercury(II) acetate 47.2
PCMBS 47.2
Potassium tetrachloroplatinate 44.4
Potassium tetranitroplatinate 44.4
Lead acetate 43.3
Potassium hexabromoplatinate 41.7
Methylmercury(II) chloride 38.8
Mersalyl 38.8
Mercury(II) bromide 36.1
Mercury(II) cyanide 33.3
Gold chloride 33.3
Platinum potassium thiocyanate 33.3
Lead nitrate 33.3
Table 2
Summary of peptide derivatization.
The numbers given are for highly reactive compounds which gave greater than
50% derivatization in a single reaction.
Peptides
Met His Cys Asp/Asn/Glu/Gln Tyr Total
Sodium acetate 7 4 9 2 3 25
Sodium cacodylate 6 3 11 1 3 24
Sodium citrate 7 0 8 0 0 15
MES 8 26 19 6 4 63
HEPES 7 7 16 5 3 38
Tris 4 3 9 2 2 20
Pt compounds 6 11 3
Hg compounds 2 7 10
Au compouds 2 4 3dichloroethylenediaminoplatinate and potassium hexachloro-
platinate all react strongly under acidic conditions. It is inter-
esting that K2IrCl6 and K2OsCl6 are observed to react
consistently with the Met, Cys and His peptides in the vast
majority of conditions examined, but the percentage of total
peptide in a reaction which forms a heavy-atom adduct is
consistently lower than that seen for other heavy-atom com-
pounds.
Another observation which is clear from the data is that a
number of compounds are highly reactive over a broad range
of buffer and pH. The 22 most reactive compounds are listed
in Table 1 and they include the seven compounds that were
previously identiﬁed as highly successful in protein-derivati-
zation experiments (Garman & Murray, 2003; Boggon &
Shapiro, 2000). Other results that stand out include the
observation that Met and Cys can be derivatized by at least
four heavy-atom compounds in all buffers (Table 2).
Methionine and histidine residues are the most reactive with
platinum compounds, while cysteine preferentially reacts with
mercury compounds. Thus, for proteins rich in methionine and
histidine platinum compounds should be the ﬁrst choice for
screening, while mercury and gold compounds become the
obvious candidates for proteins rich in free cysteines. Most
importantly, the pH-dependent and buffer-dependent heavy-
atom reactivity proﬁles enable the user to avoid experiments
with compounds that are nonreactive in speciﬁc buffers, even
in an ideal experimental scenario such as the heavy-atom
peptide experiment carried out here.
3. Assessment of protein heavy-atom derivatization
using mass spectrometry
To replace the traditional time-consuming heavy-atom
screening procedure, we utilized mass spectrometry for heavy-
atom derivative screening. This method not only enables rapid
selection and optimization of the potential derivatives, but
also eliminates the use of crystals, allowing streamlining of the
heavy-atom derivatization process. Here, we present two test
cases to illustrate the general applicability of this method.
3.1. Derivatization of FccRIII
The extracellular ligand-binding domain of the type III
human Fc receptor, FcRIII, contains two immunoglobulin-
like (Ig-like) domains with a molecular weight of 21 000 Da
as measured by electrospray ionization mass spectrometry
(ESI-MS). The derivatization reactions were prepared by
mixing 0.5–1 ml pre-dissolved heavy-atom compound solutions
at various concentrations with 5–10 mlF c RIII at 2–5 mg ml
1
in water for 30 min at room temperature before infusion of the
sample into the mass spectrometer. Two adducts of HgCl2 with
molecular weights of 21 198 and 21 398 Da that corresponded
to the addition of one and two Hg
2+ ions, respectively, were
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Figure 1
Mass-spectrometric proﬁles of FcRIII (calculated molecular weight
20 996 Da) reacted with (a) HgCl2,( b)K 2PtCl4,( c) TMLA, (d) lead
acetate or (e) KAu(CN)2. The molecular weight of the residual native
peak is labeled in each panel. The number of heavy atoms covalently
attached to the protein is indicated above the adduct peaks (taken from
Sun & Hammer, 2000).
Figure 2
ESI-MS results for gold cyanide-derivatized KIR2DL2. The KAu(CN)2-
derivatization reaction was carried out using heavy atom:protein molar
ratios of (a) 9:1 and (b) 28:1, respectively. The KAu(CN)2-derivatized
peaks are labeled 1–5. (c) Native KIR2DL2 has a molecular weight of
22 226.0 Da (taken from Sun & Hammer, 2000).detected in addition to the native peak (Fig. 1). Additionally,
FcRIII was also found to react with K2PtCl4, TMLA, lead
acetate and KAu(CN)2 (Fig. 1). Furthermore, the numbers of
heavy-atom sites found by ESI-MS largely correlated with
those found from crystallographic heavy-atom reﬁnement
(Sun & Hammer, 2000).
3.2. Derivatization of KIR2DL2
The extracellular ligand-binding region of KIR2DL2 con-
tains two Ig-like domains with a calculated molecular weight
of 22 228 Da. The crystal structure of the soluble receptor has
previously been determined using KAu(CN)2 as the heavy-
atom phasing derivative (Snyder et al., 1999). Two reactions
with molar KAu(CN)2:KIR2DL2 concentration ratios of 9:1
and 28:1, respectively, were carried out in solution for 30 min
using 6.5 mg KIR2DL2 in each reaction. ESI-MS revealed up
to ﬁve Au(CN)2 adducts in addition to the diminished native
peak (Fig. 2). The number of adducts generated by the deri-
vatization reaction in solution agreed with the number of
heavy-atom binding sites determined by X-ray diffraction
analysis (Sun & Hammer, 2000). Of the two KAu(CN)2
reactions, the reaction with the 28:1 molar ratio of gold
cyanide to native protein produced higher derivative-peak
intensities than did the 9:1 molar ratio reaction, indicating a
correlation between the mass-spectrometric peak intensity
and the concentration of the heavy atom used in the deriva-
tization reaction.
In short, mass spectrometry offers a rapid method for
heavy-atom derivative screening. Compared with conven-
tional screening by X-ray diffraction,
mass spectrometry can be used to
screen potential derivatives in solution,
thus eliminating the use of crystals.
Typical heavy-atom derivatization
reactions in solution and mass-spectro-
metric data acquisition can be
completed in minutes to hours, com-
pared with the days to weeks required
for X-ray heavy-atom derivative data
analysis. The limitation of this mass-
spectrometry-based screening tech-
nique is that it has only been used for
the detection of covalent adducts. It is
not clear whether the method can be
applied to noncovalently bound heavy
atoms such as the lanthanides, although
Na
+,C l
 and other solvent ions are
frequently detected as adducts to
proteins in mass spectrometry.
4. Derivatization by the quick-soak
method
Once heavy-atom compounds with good
reactivities in the crystallization buffer
have been identiﬁed and their ability to
react with the protein of interest has
been conﬁrmed by mass spectrometry,
the process of carrying out heavy-atom
soaks with crystals begins. In order to
streamline this process and reduce the
changes in crystals during the soaking
procedure, we have developed a quick-
soak method. This method is generally
less damaging to the crystals and tends
to produce more isomorphous crystals
and thus better phasing statistics than
conventional soaking techniques. Mass-
spectrometric measurements show that
adducts of many covalent heavy-atom
compounds are formed within minutes
research papers
Acta Cryst. (2010). D66, 358–365 Joyce et al.  Heavy-atom derivative screening 361
Table 3
Derivatization conditions and phasing statistics of lysozyme derivatives (adapted from Sun et al.,
2002).
KAuCl4 K2PtCl6
Derivatization† 10 mM,
10 min
10 mM,
24 h
1m M,
48 h
10 mM,
10 min
12 mM,
10 min
1m M,
10 min
1m M,
22 h
10 mM,
48 h
Riso 0.201 0.462 0.349 0.176 0.208 0.111 0.087 0.213
Heavy-atom peak height‡
Site 1 () 21.6 <4.0 15.7 19.3 18.2 <5.0 15.0 6.2
Site 2 () 12.8 <4.0 9.3 16.3 16.5 <5.0 10.5 11.0
Site 3 () 9.7 <4.0
† Heavy-atom soaking concentration, soaking time. ‡ The heavy-atom sites are shown as peak heights in standard
deviations from the difference Fourier (FPH  FP) map. For the KAuCl4 derivative the coordinates of sites 1, 2 and 3 are
(11.36, 11.72, 19.21), (8.49, 10.2, 14.25) and (3.30, 7.94, 9.84) A ˚ , respectively. For the K2PtCl6 derivative the
coordinates of site 1 and 2 are (10.957, 10.957, 9.23) and (6.143, 3.859, 29.992) A ˚ , respectively.
Figure 3
Experimental electron-density maps of TRII phased with HgCl2 derivatives. (a) A region of the
MAD-phased electron-density map contoured at 1 with the corresponding reﬁned model. (b)
SIRAS map produced by a 10 min quick-soak. (c) SIRAS map resulting from the long 12 h soak
(taken from Sun & Radaev, 2002).in solution (Agniswamy et al., 2008) and this rapid reaction
rate presumably also occurs within crystals. In the following
section, we present a comparison of quick-soak-derived
phasing statistics with those obtained using conventional
longer soaks for crystals of a number of test cases including
lysozyme, FcRIII, the extracellular domain of a type II
human transforming growth factor  (TGF-) receptor
(TRII) and the natural killer cell receptor NKG2D in
complex with its ligand ULBP3.
4.1. Derivatization of hen egg-white lysozyme crystals
Two compounds previously known to derivatize lysozyme,
KAuCl4 and K2PtCl6, were chosen to identify the optimal time
for crystal soaking and the optimal heavy-metal concentra-
tions that should be used. Both of the original derivatives were
obtained after 7–14 d of soaking in the heavy-atom solution
(Blake et al., 1974). For the quick-soak method, the lysozyme
crystals were soaked in a 10 mM solution of heavy-atom
compound for 10 min, designated hereafter as the (10 mM,
10 min) soak. The data for KAuCl4 derivatives were collected
from crystals using three different soaking conditions:
(10 mM, 10 min), (10 mM, 24 h) and (1 mM, 48 h) (Table 3).
Only the 10 min soak produced diffraction data that were
similar in quality to the native data as judged by diffraction
resolution, Rmerge and I/(I) for the outermost resolution shell
of reﬂections. Both the 24 and 48 h soaked crystals diffracted
to lower resolution than did the native crystal. Interestingly,
while the 10 min soaks resulted in the smallest isomorphous R
factors (Riso), the heavy-atom occupancies were the highest.
Similar results were observed with the 10 min K2PtCl6 soak,
which resulted in no reduction in the diffraction resolution of
the lysozyme crystal, whereas once again the 22 and 48 h soaks
resulted in weaker diffraction and lower heavy-atom occu-
pancies (Table 3). When the data from three 10 min soaks with
1, 10 and 12.3 mM K2PtCl6 solutions were compared, the
results showed signiﬁcantly weaker binding of Pt in the 1 mM
soak compared with the 10 and 12.3 mM soaks. This suggests
that the quick-soak method optimally requires a higher
concentration of heavy-atom solution. While lengthy deriva-
tization reactions ought to result in greater heavy-atom
attachment, the observed lower heavy-atom occupancy asso-
ciated with the longer soaks can be explained by a concomi-
tant increase in non-isomorphism of the crystal arising from
the longer soaking time. The lack of isomorphism can also be
seen by the change in unit-cell parameters associated with the
longer soaks, which is absent in the crystals soaked using the
quick-soak procedure.
4.2. Derivatives of FccRIII crystals
FcRIII crystallized in space group P21212 and diffracted to
1.8 A ˚ resolution. Both trimethyllead acetate (TMLA) and
HgCl2 reacted with the receptor as shown by mass spectro-
metry. Diffraction data were collected from three TMLA-
derivatization soaks: (5 mM, 10 min), (10 mM, 10 min) and
(10 mM, 24 h). Similar to the lysozyme tests, the (10 mM,
10 min) soak resulted in better heavy-atom derivatization than
the 24 h soak (Table 4). A comparison between the two 10 min
soaks with 5 and 10 mM TMLA showed that the lead occu-
pancies in the (10 mM, 10 min) soak are more than twofold
higher than those in the (5 mM, 10 min) soak, again indicating
that the higher concentration of heavy-atom solution has a
direct effect on derivatization. For HgCl2 soaking, FcRIII
crystals were soaked in saturated HgCl2 (less than 5 mM)
solution for different periods of time. Overnight soaks led to
crystal lattice disorder and loss of diffraction. While both the
10 min and 2 h soaks resulted in Hg derivatization (Table 4),
the two major Hg-binding sites in the 2 h soak have higher
occupancies than those obtained from the 10 min soak,
suggesting that complete HgCl2 derivatization took longer
than the TMLA-derivatization reaction and that the optimal
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Table 4
Derivatization conditions and phasing statistics of FcRIII derivatives
(adapted from Sun et al., 2002).
TMLA HgCl2
Derivatization† 5 mM,
10 min
10 mM,
10 min
10 mM,
24 h
Saturated,
10 min
Saturated,
2h
Riso 0.093 0.09 0.168 0.119 0.273
Heavy-atom peak height‡
Site 1 () 6.7 17.8 <5.0 7.6 24.4
Site 2 () 6.0 12.8 <5.0 5.2 16.4
† Heavy-atom soaking concentration, soaking time. ‡ The heavy-atom sites are shown
as peak heights in standard deviations from the difference Fourier (FPH  FP) map. The
coordinates of sites 1 and 2 of the TMLA derivatives are (111.99, 12.54, 13.41) and (88.49,
21.42, 23.78) A ˚ , respectively. The coordinates of sites 1 and 2 of the HgCl2 derivatives are
(80.27, 1.80, 27.71) and (104.52, 7.78, 29.52) A ˚ , respectively
Figure 4
Experimental electron-density maps of the NKG2D–ULPB3 complex
phased with a quick-soaked K2PtCl4 derivative. (a) Electron-density map
generated from combined MAD and SIR phases contoured at 1
displaying a -strand of ULBP3. (b) Electron-density map produced from
MAD phases alone showing the same region as (a) (taken from Sun &
Radaev, 2002).length of time for soaking may vary depending on the heavy-
atom compound and the protein under study.
4.3. Phasing of the TbRII structure
The extracellular domain of the type II transforming growth
factor- (TGF-) receptor (TRII) has been expressed and
crystallized (Boesen et al., 2000). Using mass spectrometry,
HgCl2 was shown to derivatize TRII in solution. Crystals of
TRII were derivatized by soaking with saturated HgCl2
solution for 10 min and diffraction data were collected around
the Hg LIII absorption edge for structure determination using
MAD. For comparison, equivalent MAD data sets were also
collected from a crystal derivatized for 12 h using a heavy-
atom soaking solution identical to that used in the quick-soak
experiment. Overall, the phasing statistics are very similar for
both the quick-soak and the 12 h soak, illustrating the effec-
tiveness of the quick-soak in derivatization and subsequent
phasing. Again, the calculated Riso of the quick-soak deriva-
tive (0.23) is lower than that of the longer soak (0.37), indi-
cating increased crystal non-isomorphism as a result of
prolonged soaking. This is also reﬂected in a 1.1 A ˚ change in
the unit-cell parameter a in the case of the crystal soaked for
12 h compared with a 0.5 A ˚ change in a for the crystal soaked
for 10 min. Since phases derived from isomorphous replace-
ment (FPH  FP) terms are affected by non-isomorphism
between a derivative data set and a native data set, they are
often inconsistent with phases derived from anomalous and
multi-wavelength components. Attempts to combine these
phases often yield electron-density maps that are poorer in
quality than those calculated from MAD phasing alone. In this
example, the combined phases (SIRAS map) from the shorter
soak are not only better than those
obtained from the longer soak but they
are also better than the MAD phased
map, clearly demonstrating the beneﬁts
of a quick-soak in reducing crystal non-
isomorphism (Fig. 3).
4.4. Phasing of the NKG2D–ULBP3
crystal
NKG2D is a 14 kDa C-type lectin-
like receptor expressed on the surface
of natural killer cells and certain T cells.
ULBP3 is a 24 kDa class I major histo-
compatibility complex antigen-like
molecule and a ligand of NKG2D.
The crystals of the NKG2D–ULBP3
complex diffracted to 2.6 A ˚ resolution
(Radaev et al., 2001). K2PtCl4, KAuBr4
and KAuCl4 showed heavy-atom
adducts in mass-spectrometric analysis.
Attempts to soak NKG2D–ULBP3
crystals for 24 h in solutions containing
1m M of these heavy-atom compounds
all resulted in lattice disorder and loss of
diffraction beyond 6 A ˚ resolution. In
contrast, a quick-soak of the crystals in
10 mM K2PtCl4 for 10 min resulted in
no visual deterioration of the diffrac-
tion. A total of four Pt heavy-atom sites
were determined and heavy-atom
phasing resulted in an overall ﬁgure of
merit of 0.41. Again, the combined SIR
and MAD phases resulted in a better
electron-density map than that calcu-
lated from the MAD phases alone
(Fig. 4). It is worth emphasizing that
only the quick-soak procedure resulted
in a usable phasing derivative in this
case and that all the longer soaks
resulted in large crystal lattice disorder.
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Figure 5
A ﬂow chart outlining the major steps in the rational approach for heavy-atom derivative screening.Thus, the brief soaks are highly advantageous compared with
conventional longer soaks for low-resolution diffracting crys-
tals that could easily be damaged by heavy-atom soaks.
Compared with longer conventional soaks, the quick-soak
method offers three main advantages. Firstly, it generally
preserves the diffraction resolution of a crystal. In all exam-
ples tested, the quick-soak derivatization reactions resulted in
no obvious deterioration of diffraction resolution compared
with that of a native crystal. In contrast, data collected from
overnight-soaked crystals often showed a reduction in both
resolution and data quality. In some cases, the longer over-
night soaks resulted in complete lattice disorder. Secondly, the
quick-soak method minimizes the non-isomorphism asso-
ciated with a derivative data set. This is reﬂected in smaller
unit-cell parameter changes and better phasing statistics in all
the quick-soak examples described here. Thirdly, the quick-
soak method saves time and offers the potential for high-
throughput ‘on-the-ﬂy’ real-time heavy-atom screening.
4.5. Choice of heavy-atom concentration and soaking time
In conventional soaks, the concentration of a heavy-atom
reagent is often limited by its adverse effects on the crystal
lattice and subsequently the diffraction resolution. These
adverse effects are negligible in all four quick-soak test cases
described above. Consequently, for the beneﬁt of thorough
derivatization, a higher concentration of heavy-atom reagents
can and should be used in quick-soak experiments. In both the
lysozyme and FcRIII examples the highest heavy-atom
occupancies were obtained with a 10 mM or higher concen-
trations of the heavy-atom reagent. Most of the quick-soak
experiments were carried out for time periods between 10 min
and 2 h. The optimum soaking time is a
balance between achieving high heavy-
atom binding occupancy and mini-
mizing crystal non-isomorphism arising
from the soaking procedure.
5. Applying rational heavy-atom
screening to lysozyme
The rational heavy-atom screening
strategy is summarized in a ﬂow chart
(Fig. 5). As a test case, we applied this
rational approach to lysozyme in order
to illustrate the gains that can be
achieved using this strategy.
Under the crystallization conditions
of hen egg-white lysozyme, 15 heavy-
atom compounds are predicted to be
highly reactive based on the lysozyme
amino-acid sequence (Table 5). Only
two of these 15 compounds, K2PtCl4 and
K2PtBr4, overlap with those phasing
derivatives used by Blake (1968) in the
initial structure determination. Several
compounds known to derivatize lyso-
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Table 5
Rational heavy-atom screening of lysozyme (adapted from Agniswamy et
al., 2008).
The extent of heavy-atom reactivity was evaluated based on the peak heights
of observed derivatives from mass-spectrometric experiments and was
assigned on a four-level scale as either , +, ++ or +++, which equate to no
signiﬁcant derivative adduct formation and derivative adducts with peak
heights less than 25%, between 25 and 50% and above 50% of the native peak
intensity, respectively.
Compound Peptide reactivity Lysozyme reactivity
MHTS ND Blake et al. (1962)
K2PdCl4 ND Blake et al. (1962)
K2HgBr4 ND Blake (1968)
K2HgI4  Blake et al. (1962)
PCMB  Blake (1968)
PCMBS + Blake (1968)
K2PtCl6 + Blake (1968)
K2AuCl4 ++ Blake (1968)
K2PtBr4 +++ +; Blake (1968)
K2PtCl4 +++ +++; Blake (1968)
K2PtBr6 +++ +++
Methylmercury(II) acetate +++ +++
Ethylmercury phosphate +++ +++
Mercury(II) acetate +++ +++
TELA +++ +
Lead nitrate +++ +++
Lead acetate +++ +++
Diaminoplatinum dinitrate +++ +
Gold(II) chloride +++ +
Thiomersal +++ 
Mersalyl +++ 
Mercury(II) bromide +++ 
Methylmercury(II) chloride +++ 
Mercury(II) iodide 
Methylmercury(II) bromide 
K2Pt(CN)4  +++
K2PtI6 
Gold sodium thiosulfate 
Hexaphenyllead 
Figure 6
Difference Fourier (Fo  Fc) maps calculated for lysozyme derivatized with lead acetate (blue
density) andwith potassium tetracyanoplatinate(II) (red density) andcontoured atthe 3 level. The
structure of lysozyme is shown in ribbon representation, with the residues coordinating heavy atoms
shown in ball-and-stick representation. PyMOL was used to generate the ﬁgure (taken from
Agniswamy et al., 2008).zyme are not highly reactive with the model peptides in the
lysozyme crystallization buffer, suggesting that they may not
be optimal for phasing. These 15 heavy-atom compounds were
assessed by mass spectrometry to conﬁrm their reactivity with
lysozyme. Except for four mercury compounds that were
selected based on their reactivities with the cysteine peptide,
the remaining 11 compounds all reacted with lysozyme in
solution (Table 5). The failure of the four mercury compounds
to derivatize lysozyme is likely to be a consequence of the lack
of freely accessible cysteines in the protein. When a protein
contains free cysteines they can be highly reactive with many
heavy-atom compounds and thus may play a critical role in
successful derivatization. In addition, six compounds which
failed to react with the peptides in the sodium acetate buffers
were selected for test reactions with lysozyme in order to
verify that these compounds are less reactive (Table 5). With
the exception of K2Pt(CN)4, no adduct formation was
observed between lysozyme and these test compounds.
Lead acetate, one of the compounds identiﬁed as highly
reactive in this study but not previously known to derivatize
lysozyme, and K2Pt(CN)4 were used to soak lysozyme crystals
using the quick-soak method. The soaked crystals were then
analyzed to assess the quality of the data obtained and the
extent of derivatization achieved. Three lead-binding sites
were identiﬁed from the difference Fourier map (Fig. 6). In
contrast, only a minor site was observed in the case of the
K2Pt(CN)4-derivatized crystal. All three lead-binding sites
exhibited higher occupancy than the platinum site and the
lead derivative also had a higher ﬁgure of merit, indicating its
potential as a phasing derivative (Table 6). The results show
that while compounds which failed to react with the model
peptides may still derivatize a protein in solution, they are
likely to produce only minor binding sites in the crystal
structure.
6. Conclusion
In summary, it is possible to streamline the conventional
heavy-atom derivatization procedure. Use of heavy-atom
reactivity proﬁles allows the rational selection of potential
heavy-atom compounds that are amenable to derivatization
under experimental crystal-growth conditions. These potential
candidates can then be evaluated for their ability to derivatize
the target protein by mass spectrometry. In principle, both
heavy-atom concentration and soaking time can be optimized
using mass spectrometry. Upon veriﬁcation by mass spectro-
metry in solution, derivatization reactions in crystals can be
carried out using the quick-soak method to minimize non-
isomorphism between native and derivatized crystals and thus
improve phasing. Overall, the method replaces the most
laborious and time-consuming steps in conventional heavy-
atom derivatizations with a prediction-based rational
approach that should increase the likelihood of successful
derivatization and maximize the quality of heavy-atom phases.
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Table 6
Phasing statistics of heavy-atom derivatization of lysozyme using two test
compounds (adapted from Agniswamy et al., 2008).
Values in parentheses are for the highest resolution shell.
Lead acetate K2Pt(CN)4
Unit-cell parameters (A ˚ )
a 78.967 77.977
b 78.967 77.977
c 37.104 36.983
Resolution (A ˚ ) 50–1.84 (1.91–1.84) 50–2.5 (2.59–2.5)
Completeness (%) 97.4 (94.3) 87.5 (91.6)
Rmerge 0.051 (0.165) 0.11 (0.362)
I/(I) 29.46 (9.77) 11.41 (3.24)
Riso 0.109 0.319
Figure of merit 0.235 0.144
Heavy-atom peak height (in )
Site 1 14.6 4.91
Site 2 10.92 N/A
Site 3 5.16 N/A